TrademarkDir
OPOPS
DEAD

Serial Number

76328935

Owner

Optimer Pharmaceuticals, Inc.

Attorney

John L. DuPre'

First Use Date

Oct 1, 2000

Filing Date

Oct 23, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OPOPS Trademark

Serial Number: 76328935 • Registration: 2621070

OPOPS is a trademark filed by Optimer Pharmaceuticals, Inc. on October 23, 2001. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Optimer Pharmaceuticals, Inc. (17 trademarks)

Suite C
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

October 23, 2001

Registration Date

September 17, 2002

First Use Anywhere

October 1, 2000

First Use in Commerce

October 1, 2000

Published for Opposition

June 25, 2002

Cancellation Date

April 19, 2013

Goods & Services

Consultation, research and development services in the field of the production of chemicals for human and animal health

Filing History

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2014 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2013 TCCA
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Apr 19, 2013 CAEX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2011 REAP
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 30, 2008 C15A
ASSIGNED TO PARALEGAL
Sep 5, 2008 PLGL
TEAS SECTION 8 & 15 RECEIVED
Sep 3, 2008 E815
CASE FILE IN TICRS
Dec 4, 2007 CFIT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2007 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 16, 2007 REAP
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2002 R.PR
PUBLISHED FOR OPPOSITION
Jun 25, 2002 PUBO
NOTICE OF PUBLICATION
Jun 5, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2002 CNSA
EXAMINER'S AMENDMENT MAILED
Jan 25, 2002 CNEA
ASSIGNED TO EXAMINER
Jan 9, 2002 DOCK

Related Trademarks

More from this Owner

ACCESS DIFICID

ACCESS DIFICID

ACCESS DIFICID

ACCESS DIFICID

DIFICID RX ASSIST

DIFICID RX ASSIST

OPTIMER PHARMACEUTICALS

OPTIMER PHARMACEUTICALS

OPTIMER

OPTIMER

OPTIMER

OPTIMER